F
600781
vs
S
Shanghai Composite
Over the past 12 months, FUREN Group Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of 0% compared to the Shanghai Composite's +22% growth.
Stocks Performance
600781 vs Shanghai Composite
Performance Gap
600781 vs Shanghai Composite
Performance By Year
600781 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
FUREN Group Pharmaceutical Co Ltd
Glance View
FUREN Group Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Zhengzhou, Henan and currently employs 2,916 full-time employees. The firm's principal business is the manufacture of proprietary Chinese medicines, including capsules, tablets, granules, gels, injections, suspensions, drops, syrups and others. The firm mainly distributes its products in the domestic market.